LOC728393 Activators
LOC728393 is a designation that might refer to a specific genetic element or molecular sequence within the human genome, potentially expressed as a protein or an enzyme with a particular function. Activators of this element would be chemicals that can increase its expression or activity within a biological context. These molecules would interact with the regulatory regions of the gene or the biochemical pathways that control the production or action of the protein encoded by LOC728393. The exact mechanisms of activation could vary, including allosteric modulation, direct binding to promoter regions to enhance transcription, or stabilization of the mRNA to increase translation efficiency. This class of chemicals would be characterized by their ability to influence the activity of LOC728393, potentially affecting the levels or functionality of the associated protein product.
The chemical structure and properties of LOC728393 activators would be diverse, reflecting the variety of potential mechanisms through which they could exert their effect. These activators may be small organic molecules, peptides, or even larger biomolecules that have been optimized for high affinity and specificity to their target. The interaction between an activator and LOC728393 would be the result of a finely tuned recognition process, often involving multiple points of contact to ensure selectivity. The design of such activators would require detailed knowledge of the structure and regulatory mechanisms of LOC728393, utilizing techniques such as high-throughput screening or biophysical methods like X-ray crystallography or NMR spectroscopy to identify molecules capable of modulating its activity. While the chemical space of potential activators is vast, each activator would be characterized by its unique chemical signature and its ability to modulate LOC728393 without affecting other genes or proteins.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which is involved in regulating numerous cellular processes. PKC activation can lead to phosphorylation of substrates that modulate the activity of LOC728393, thereby potentially enhancing its functional activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent signaling pathways. Given that LOC728393 is part of cellular processes regulated by calcium, Ionomycin may enhance LOC728393's activity through these pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is a bioactive lipid that can activate sphingosine-1-phosphate receptors and subsequent downstream signaling pathways. This activation can enhance the activity of LOC728393 by engaging in signaling cascades where LOC728393 is involved. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic catecholamine that activates beta-adrenergic receptors, leading to increased cAMP production. The elevation of cAMP may subsequently enhance LOC728393 activity through cAMP-dependent pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol compound known to inhibit certain protein kinases. By doing so, it may remove inhibitory phosphorylation events and enhance the activity of LOC728393 through de-repression of its signaling pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases (PDEs), enzymes that degrade cAMP and cGMP. By inhibiting PDEs, IBMX can increase cAMP levels, potentially enhancing LOC728393 activity through cAMP-dependent signaling mechanisms. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cell-permeable analog of cAMP that directly activates cAMP-dependent pathways. This compound could enhance LOC728393 activity by mimicking the effect of endogenous cAMP and activating pathways that LOC728393 is associated with. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels, similar to Ionomycin. This increase in calcium can activate signaling pathways that potentially enhance the activity of LOC728393. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a stable analog of cAMP that activates cAMP-dependent protein kinases. By doing so, it could enhance LOC728393 activity by influencing cellular processes in which LOC728393 is involved. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of phosphoinositide 3-kinases (PI3K), which can alter downstream signaling pathways, including AKT signaling. By modulating these pathways, LY294002 may indirectly enhance LOC728393 activity if LOC728393 is functionally connected to them. | ||||||